Growing wave of hospital, health system mega-mergers means changing dynamics for pathology, clinical lab medicine Dark Daily
Large and financially-stable multi-hospital health systems are racing to form regional mega-systems. It's a strategy to get ahead of the Affordable Care Act's mandate to improve quality and increase efficiency through coordinated care across the entire care continuum. This growing national trend means further consolidation of clinical laboratory testing services within the merging organizations.
CDC installing cameras in labs in agency-wide safety push Reuters
The U.S. Centers for Disease Control and Prevention has introduced camera monitoring of workers in its highest-level biosafety laboratories as it seeks to restore public faith in its procedures after a series of mishaps, agency officials tell Reuters.
Top legal minds against FDA's proposal to regulate lab tests RAPS
A new legal whitepaper authored by two of America's most prominent lawyers argues that the U.S. Food and Drug Administration's plan to regulate lab developed tests (LDTs) more similarly to traditional medical devices lacks legal justification and is therefore unlawful.
UnitedHealthcare pushes back start date for making claims-payment decisions Dark Daily
Physicians, pathologists, and clinical laboratories in Florida got a late Christmas present. UnitedHealthcare postponed the date when its medical laboratory benefit-management pilot program in Florida, administered by BeaconLBS, would affect claims payments. This was welcome news, because, beginning Jan. 1, if physicians serving UHC patients had failed to use the BeaconLBS system to obtain pre-notification or pre-authorization for 82 medical laboratory tests, the physicians or labs performing the tests would not be paid by UHC—nor could clinical labs and pathology groups in the UHC provider network bill patients for these tests.
Scientists identify 'high-priority' chemicals that may cause breast cancer Medical News Today
From May 14: An estimated 12.4 percent of women born in the U.S. today will develop breast cancer at some point during their lives. Past research has indicated that exposure to some chemicals may increase the risk of breast cancer. Now, a new study has identified 17 "high-priority" chemicals women should avoid in order to reduce such risk and demonstrates how their presence can be detected.
Study spotlights high prices of medical lab tests charged by California hospitals Dark Daily
Clinical laboratories owned by hospitals and health systems should take note of a public study of hospital laboratory test prices that was conducted by researchers at the University of California at San Francisco. It was published this summer and showed a remarkable range of prices for medical laboratory tests charged by California hospitals. How about a charge of $10,169 for a routine blood cholesterol test? This was one finding a study discussed in the August 2014 issue of the British Medical Journal Open blog.
Real-time genome sequencing helps control hospital outbreak Medical Xpress
Pioneering use of whole genome sequencing in real time to help control a hospital outbreak is reported in an article published in the open access journal Genome Medicine. The research corroborates the use of the technique as a rapid and cost-effective way of tracking and controlling the spread of drug-resistant hospital pathogens.
New business model for medical billing companies By Mick Raich
The key in any industry is to make a margin — that difference between cost and revenue, the part you get to take home every two weeks so little Tommy can have a new iPad. As change takes place, companies that fall short of this margin inevitably fail. They may leverage themselves with loans or lower their costs by decreasing output, but sooner or later the bills have to be paid. In the medical billing industry, companies have literally searched far and wide for this margin. Over the past 10 years we have seen considerable use of Business Process Outsourcing firms that handle various parts of the billing process overseas.
'Genetic Testing Handbook' provides pathologists, lab managers with comprehensive reference for clinical genome and exome sequencing Dark Daily
Clinical use of gene sequencing information has advanced to the point where a team of genetic experts has compiled and issued the Genetic Testing Handbook. The goal of the clinical genome and exome sequencing (CGES) handbook is to provide clinicians — including pathologists and clinical laboratory scientists — with a useful reference tool.
You are invited to FSP's 41st Annual Anatomic Pathology Conference FSP
It will be another Sensational program featuring presentations on cutting edge pathology topics. Click here for more information and to register.